Trial Profile
An Open Study to Evaluate the Efficacy, Safety and Sustained Effect of Clevudine Monotherapy or Adefovir and Clevudine Combination in Proportion to Roadmap Concept in Patients With Chronic Hepatitis B.
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 22 Dec 2014
Price :
$35
*
At a glance
- Drugs Adefovir (Primary) ; Clevudine (Primary)
- Indications Hepatitis B
- Focus Therapeutic Use
- Sponsors Bukwang Pharmaceutical
- 17 Dec 2014 Status changed from active, no longer recruiting to discontinued as reported by ClinicalTrials.gov.
- 25 Jul 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 24 Dec 2010 New trial record